{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:34:45Z","timestamp":1787027685873,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Arkansas Bioscience Institute and Arkansas Children\u2019s Research Institute (RH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Excessive weight and obesity are the leading risk factors for the development of chronic diseases, including diabetes. Metformin is capable of significantly improving coexisting complications of diabetes. We used a metabolomics approach to examine the effects of metformin administration on lean and obese (fa\/fa) Zucker rats. After 1 week of acclimation, twenty-eight 5-week-old female lean and obese rats were randomly assigned to and maintained in the following four groups (seven rats\/group) for 10 weeks: (1) lean control (LC); (2) obese control (OC); (3) lean metformin (LM); and (4) obese metformin (OM). At the end of 10 weeks, serum was collected and analyzed using HPLC with electrochemical detection, HPLC with UV detection, and liquid chromatography mass spectrometry. We selected 50 metabolites\u2019 peaks that were shared by all four groups of rats. Peak heights, as a defining factor, generally decreased in metformin-treated lean rats vs. untreated lean controls (3 LM:16 LC). Peak heights generally increased in metformin-treated obese rats vs. untreated obese controls (14 OM:5 OC). Overall, individual peaks were distributed as 11 that represented only lean rats, 11 that represented only obese rats, and 8 that were common among both lean and obese rats. In future studies, we will use a targeted metabolomics approach to identify those metabolites, map them to biochemical pathways and create a list of biomarkers. In summary, the current study contributed to a better understanding of the basic metabolic changes of lean and obese rats and demonstrated that both obesity and metformin make a significant impact on the metabolome of Zucker rats.<\/jats:p>","DOI":"10.3390\/biom13081234","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:11:22Z","timestamp":1691662282000},"page":"1234","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Stepan","family":"Melnyk","sequence":"first","affiliation":[{"name":"Arkansas Children\u2019s Research Institute, Little Rock, AR 72202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-8478","authenticated-orcid":false,"given":"Reza","family":"Hakkak","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Research Institute, Little Rock, AR 72202, USA"},{"name":"Department of Dietetics and Nutrition, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"},{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115012","DOI":"10.1016\/j.bcp.2022.115012","article-title":"Obesity I: Overview and molecular and biochemical mechanisms","volume":"199","author":"Lustig","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","article-title":"The Definition and Prevalence of Obesity and Metabolic Syndrome","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acsptsci.1c00167","article-title":"Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?","volume":"4","author":"Ala","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Guh, D.P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C.L., and Anis, A.H. (2009). The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health, 9.","DOI":"10.1186\/1471-2458-9-88"},{"key":"ref_5","unstructured":"Solis-Herrera, C., Triplitt, C., Cersosimo, E., and DeFronzo, R.A. (2021). Endotext, MDText.com, Inc.. Internet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cnur.2021.07.008","article-title":"Obesity and Diabetes","volume":"56","author":"Aras","year":"2021","journal-title":"Nurs. Clin. N. Am."},{"key":"ref_7","first-page":"S176","article-title":"Obesity: Definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s43440-021-00334-z","article-title":"An update on mode of ac-tion of metformin in modulation of meta-inflammation and inflammaging","volume":"74","author":"Khodadadi","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a000588","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: An emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13293-022-00440-4","article-title":"Sex differences in the human metabolome","volume":"13","author":"Costanzo","year":"2022","journal-title":"Biol. Sex Differ."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kim, H.W. (2021). Metabolomic Approaches to Investigate the Effect of Metformin: An Overview. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910275"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xie, B., Waters, M.J., and Schirra, H.J. (2012). Investigating Potential Mechanisms of Obesity by Metabolomics. J. Biomed. Biotechnol., 805683.","DOI":"10.1155\/2012\/805683"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"716404","DOI":"10.1155\/2012\/716404","article-title":"The role of metformin in the management of NAFLD","volume":"2012","author":"Mazza","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1027484","DOI":"10.3389\/fendo.2022.1027484","article-title":"Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3892\/br.2021.1425","article-title":"Effects of Obesity and 10 Weeks of Metformin Treatment on Liver Steatosis","volume":"14","author":"Hakkak","year":"2021","journal-title":"J. Biomed. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"834776","DOI":"10.3389\/fmicb.2022.834776","article-title":"Short-term Metformin Treatment En-riches Bacteroides dorei in Obese Liver Steatosis Zucker Rat Model","volume":"13","author":"Robeson","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_17","first-page":"6","article-title":"Fat accretion and growth in the rat","volume":"80","author":"Zucker","year":"1963","journal-title":"J. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/oxfordjournals.jhered.a107093","article-title":"Fatty, a new mutation in the rat","volume":"52","author":"Zucker","year":"1961","journal-title":"J. Hered."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.271.5251.994","article-title":"Phenotypes of mouse \u2018diabetes\u2019 and rat \u2018fatty\u2019 due to mutations in the OB (leptin) receptor","volume":"271","author":"Chua","year":"1996","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","article-title":"Identification and expression cloning of a leptin receptor, OB-R","volume":"83","author":"Tartaglia","year":"1995","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1210\/endo-90-5-1320","article-title":"Insulin and obesity in the Zucker genetically obese rat \u201cfatty\u201d","volume":"90","author":"Zucker","year":"1971","journal-title":"Endocrinology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Melnyk, S., and Hakkak, R. (2022). Metabolic Status of Lean and Obese Zucker Rats Based on Untarget-ed and Targeted Metabolomics Analysis of Serum. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010153"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0955-2863(99)00033-9","article-title":"A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection","volume":"10","author":"Melnyk","year":"1999","journal-title":"J. Nutr. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinchem\/46.2.265","article-title":"Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: Alter-ations with plasma homocysteine and pyridoxal 5\u2032-phosphate concentrations","volume":"46","author":"Melnyk","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dong, Y., Chen, Y.T., Yang, Y.X., Shou, D., and Li, C.Y. (2016). Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination. Molecules, 21.","DOI":"10.3390\/molecules21111446"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, H., Teng, Y., Li, S., Li, Y., Li, H., Jiao, L., and Wu, W. (2021). UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats. Molecules, 26.","DOI":"10.3390\/molecules26216657"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biopha.2017.12.023","article-title":"Metformin treatment decreases nitroxidative stress, restores nitric oxide bioavailability and endothelial function beyond glucose control","volume":"98","author":"Sambe","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/CIRCIMAGING.108.843227","article-title":"In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: Differential efficacy of metformin and rosig-litazone monotherapy","volume":"2","author":"Shoghi","year":"2009","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"155223","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: Is it a drug for all reasons and diseases?","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13098-019-0491-1","article-title":"Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats","volume":"11","author":"Sui","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5114\/pedm.2021.107166","article-title":"Metformin\u2014A new approach","volume":"27","year":"2021","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhou, J., Massey, S., Story, D., and Li, L. (2018). Metformin: An Old Drug with New Applications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102863"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1096\/fj.03-0971fje","article-title":"Cysteine\/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control","volume":"18","author":"Jones","year":"2004","journal-title":"FASEB J."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:30:10Z","timestamp":1760128210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["biom13081234"],"URL":"https:\/\/doi.org\/10.3390\/biom13081234","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}